🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
The purpose of this study is to determine the safety and efficacy of a PEPI...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-07-15
Trial ID
NCT05609994
Treatments Being Tested
This study will evaluate the safety and immunogenicity of a booster dose of...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00452686
Treatments Being Tested
The purpose of this study is to learn whether or not giving a tetanus/dipht...
Status
Completed
Location
Emory University School of Medicine
Start Date
2004-01
Trial ID
NCT00164411
Pertussis is resurging worldwide. In Africa alone it is estimated that ther...
Status
Completed
Location
MUJHU Care Ltd
Start Date
2020-10-21
Trial ID
NCT04589312
Treatments Being Tested
This clinical trial will enroll 160 participants who previously took part i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-15
Trial ID
NCT07744347
It is well recognized that older adults can contract pertussis, suffer its ...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00457249
The purpose of this study is to evaluate the efficacy of the Travelers' Dia...
Status
Completed
Location
University Medical Centre Hamburg-Eppendorf
Start Date
2009-10
Trial ID
NCT00993681
Treatments Being Tested
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519